Mirae Asset Global ETFs Holdings’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$265K Buy
34,302
+1,130
+3% +$8.24K ﹤0.01% 2202
2025
Q4
$203K Buy
33,172
+3,235
+11% +$34.9K ﹤0.01% 2344
2025
Q3
$552K Sell
29,937
-2,395
-7% -$38.5K ﹤0.01% 1822
2025
Q2
$421K Buy
32,332
+16,306
+102% +$193K ﹤0.01% 1903
2025
Q1
$172K Buy
16,026
+483
+3% +$7.67K ﹤0.01% 2394
2024
Q4
$263K Buy
15,543
+341
+2% +$6.42K ﹤0.01% 2246
2024
Q3
$350K Buy
15,202
+876
+6% +$18.7K ﹤0.01% 2092
2024
Q2
$349K Buy
+14,326
New +$434K ﹤0.01% 1982

Other funds holding ARCT